Unknown

Dataset Information

0

Impact of Delays in Diagnosis on Healthcare Costs Associated With Blastomycosis, Coccidioidomycosis, and Histoplasmosis in a Commercially Insured Population

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC12378736 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Symptoms in Blastomycosis, Coccidioidomycosis, and Histoplasmosis Versus Other Respiratory Illnesses in Commercially Insured Adult Outpatients-United States, 2016-2017.
| S-EPMC8340310 | biostudies-literature
Unknown Histoplasmosis-related Healthcare Use, Diagnosis, and Treatment in a Commercially Insured Population, United States.
| S-EPMC6821563 | biostudies-literature
Unknown Blastomycosis, Histoplasmosis, and Coccidioidomycosis in Outpatient Community-Acquired Pneumonia.
| S-EPMC12805450 | biostudies-literature
Unknown Presumed ocular histoplasmosis syndrome in a commercially insured population, United States.
| S-EPMC7069623 | biostudies-literature
Unknown Epidemiology and Geographic Distribution of Blastomycosis, Histoplasmosis, and Coccidioidomycosis, Ontario, Canada, 1990-2015.
| S-EPMC6038754 | biostudies-literature
Unknown Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population.
| S-EPMC4070631 | biostudies-literature
Unknown Healthcare Costs of <i>Clostridioides difficile</i> Infection in Commercially Insured Younger Adults.
| S-EPMC10368308 | biostudies-literature
Unknown Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant.
| S-EPMC8478735 | biostudies-literature
Unknown Utilization and Costs of Gender-Affirming Care in a Commercially Insured Transgender Population.
| S-EPMC9679590 | biostudies-literature
Unknown Persistence of Symptoms among Commercially Insured Patients with Coccidioidomycosis, United States, 2017-2023.
| S-EPMC12829482 | biostudies-literature